Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods

by Anna Grahn, Andreas Bråve, Thomas Tolfvenstam, Marie Studahl
Published 2018-06-01

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DN...

by Jorma Hinkula, Sanna Nyström, Claudia Devito, Andreas Bråve, Steven E. Applequist
Published 2019-07-01

Endocine™, N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination.

by Tina Falkeborn, Andreas Bråve, Marie Larsson, Britt Akerlind, Ulf Schröder, Jorma Hinkula
Published 2013-01-01

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.

by Anna-Karin Roos, Fredrik Eriksson, James A Timmons, Josefine Gerhardt, Ulrika Nyman, Lindvi Gudmundsdotter, Andreas Bråve, Britta Wahren, Pavel Pisa
Published 2009-01-01

DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adju...

by Steven E. Applequist, Shizuo Akira, Jorma Hinkula, Daniel X. Johansson, Ulf Schröder, Satoshi Uematsu, Björn Rissiek, Claudia Devito, Andreas Bråve, Tina Falkeborn, Sanna Nyström
Published 2013-09-01

Retrospective meta-transcriptomic identification of severe dengue in a traveller returning from Africa to Sweden, 1990

by Kristian Alfsnes, Nina Lagerqvist, Sirkka Vene, Jon Bohlin, Jenny Verner-Carlsson, David Ekqvist, Andreas Bråve, Edward C. Holmes, Weifeng Shi, John H.-O. Pettersson
Published 2021-06-01

Cellular Immunogenicity of Novel Gene Immunogens in Mice Monitored by in Vivo Imaging

by Elizaveta Starodubova, Olga Krotova, David Hallengärd, Yulia Kuzmenko, Gunnel Engström, Diana Legzdina, Oleg Latyshev, Olesja Eliseeva, Anna Karin Maltais, Vera Tunitskaya, Vadim Karpov, Andreas Bråve, Maria Isaguliants
Published 2012-11-01

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

by Andreas Mörner, Andreas Bråve, Anna-Maria Kling, Sharon Kühlmann-Berenzon, Katarina Krook, Mona Hedenskog, Irene Silhammar, Margaretha Ljungman, Ake Ortqvist, Sören Andersson, Maria Brytting, Rigmor Thorstensson, Annika Linde
Published 2012-01-01

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.

by Charlotta Nilsson, Bo Hejdeman, Karina Godoy-Ramirez, Teghesti Tecleab, Gabriella Scarlatti, Andreas Bråve, Patricia L Earl, Richard R Stout, Merlin L Robb, Robin J Shattock, Gunnel Biberfeld, Eric Sandström, Britta Wahren
Published 2015-01-01

Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses

by Hedvig Glans, Sara Gredmark-Russ, Mikaela Olausson, Sara Falck-Jones, Renata Varnaite, Wanda Christ, Kimia T. Maleki, Maria Lind Karlberg, Sandra Broddesson, Ryan Falck-Jones, Max Bell, Niclas Johansson, Anna Färnert, Anna Smed-Sörensen, Jonas Klingström, Andreas Bråve
Published 2021-05-01

Immunotherapy with an HIV-DNA Vaccine in Children and Adults

by Paolo Palma, Lindvi Gudmundsdotter, Andrea Finocchi, Lars E. Eriksson, Nadia Mora, Veronica Santilli, Angela Aquilani, Emma C. Manno, Paola Zangari, Maria Luisa Romiti, Carla Montesano, Alba Grifoni, Andreas Brave, Karl Ljungberg, Pontus Blomberg, Stefania Bernardi, Eric Sandström, Bo Hejdeman, Paolo Rossi, Britta Wahren
Published 2014-07-01